Literature DB >> 20447014

Rapid response to antipsychotic treatment on psychotic prodrome: implications from a case series.

Chen-Chung Liu1, Yi-Han Sheu, Szu-Ying Wu, Meng-Chuan Lai, Hai-Gwo Hwu.   

Abstract

The feasible intervention strategy at the prodromal state of psychosis is under debate. We report nine subjects clinically in a putative prodromal state of psychosis who responded to low-dose aripiprazole within the first week of medication. We conjecture that the pathophysiological processes might be easier to modify by antipsychotics in the prodromal state and we believe a short-term low-dose trial of antipsychotic agents is a convenient option for subjects at ultra high risk of psychosis. We urge specific attention to monitor the dissolution of psychotic-like symptoms carefully in order to have a better understanding of the pathogenesis and pharmacotherapy in the inception of psychosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447014     DOI: 10.1111/j.1440-1819.2010.02070.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  4 in total

Review 1.  Antipsychotic interventions in prodromal psychosis: safety issues.

Authors:  Chen-Chung Liu; Arsime Demjaha
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

Review 2.  Evaluation and treatment of children and adolescents with psychotic symptoms.

Authors:  Sibel Algon; James Yi; Monica E Calkins; Christian Kohler; Karin E Borgmann-Winter
Journal:  Curr Psychiatry Rep       Date:  2012-04       Impact factor: 5.285

3.  Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals.

Authors:  JunJie Wang; TianHong Zhang; LiHua Xu; YanYan Wei; XiaoChen Tang; YeGang Hu; HuiRu Cui; YingYing Tang; ChunBo Li; Zheng Ling; JiJun Wang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-09-18       Impact factor: 5.270

4.  Long-term Efficacy and Tolerability of Perospirone for Young Help-seeking People at Clinical High Risk: a Preliminary Open Trial.

Authors:  Naohisa Tsujino; Takahiro Nemoto; Keiko Morita; Naoyuki Katagiri; Shinya Ito; Masafumi Mizuno
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-12-24       Impact factor: 2.582

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.